Thermo Fisher Scientific

Vaxcyte Strikes up to $1B Fill-Finish Manufacturing Deal with Thermo Fisher at North Carolina Facility

3 weeks ago talkbio0Tagged biomanufacturing, commercial supply chain, Manufacturing, North Carolina, PCVs, pneumococcal conjugate vaccines, production, Thermo Fisher Scientific, United States, Vaccines, VAX-24, VAX-31, Vaxcyte

Vaxcyte; Thermo Fisher Scientific; fill-finish manufacturing; North Carolina; pneumococcal conjugate vaccines; PCVs; VAX-31; VAX-24; commercial supply chain; biomanufacturing; U.S. vaccine production; $1 billion deal

Thermo Fisher Scientific Continues Workforce Reduction with 300 Layoffs in Massachusetts

9 months ago talkbio0Tagged Biotechnology, cost-cutting measures, Industry, Massachusetts (geographic location), Thermo Fisher Scientific, Viral Vector

Thermo Fisher Scientific, layoffs, Massachusetts, viral vector production, workforce reduction, biotechnology industry, cost-cutting measures

Thermo Fisher Forecasts Revenue Growth in 2025 Amid Easing Market Challenges

1 year ago talkbio0Tagged 2025, Analytical Instruments, Growth, headwinds, Laboratory Products, pharmaceutical sector, Thermo Fisher Scientific

Thermo Fisher Scientific, revenue forecast, 2025 growth, easing headwinds, biotech funding, pharmaceutical sector, laboratory products, analytical instruments.